<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340045</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Asian Flush Gene Variant Enhances Cellular Immunogenicity of COVID-19 Vaccine: Prospective Observation in the Japanese General Population.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1015</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12091015</ELocationID><Abstract><AbstractText>We previously reported a reduced humoral immune response to the COVID-19 vaccines. Subsequently, we observed a lower susceptibility to COVID-19 in individuals carrying the <i>ALDH2</i> rs671 variant through a web-based retrospective survey. Based on these findings, we hypothesized that rs671 variant was beneficial for cellular immunity against COVID-19. Using the IFN-γ enzyme-linked immunospot (ELISPOT) assay, we assessed cellular immunity before and after COVID-19 vaccination in two subcohorts of a previously reported cohort. Subcohort 1 (26 participants) had six repeated observations at baseline after one to three doses, whereas subcohort 2 (19 participants) had two observations before and after the third dose. ELISPOT counts at six months after the second dose increased from baseline in carriers of the rs671 variant but not in non-carriers. A positive effect of rs671 on ELISPOT counts was estimated using a mixed model (183 observations from 45 participants), including the random effect of subcohort, repeated measures, and fixed effects of vaccine type, age, sex, height, lifestyle, steroid use, and allergic disease. There was no association between ELISPOT counts and specific IgG levels, suggesting a limitation in estimating protective potential by humoral response. Our sequential observational studies suggest a beneficial effect of the rs671 variant in SARS-CoV-2 infection via enhanced cellular immune response, providing a potential basis for optimizing preventive measures and drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bogahawaththa</LastName><ForeName>Sudarma</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7914-4095</Identifier><AffiliationInfo><Affiliation>Laboratory of Biochemistry, Department of Applied Biochemistry and Food Science, Faculty of Agriculture, Saga University, Honjo, Saga 840-8502, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social and Environmental Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hara</LastName><ForeName>Megumi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8708-3237</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, Faculty of Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Takuma</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Faculty of Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Center, Saga University Hospital, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaka</LastName><ForeName>Chiharu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Faculty of Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition, KENTO Innovation Park NK Building, 3-17, Senriokashinmachi, Settsu 566-0002, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawada</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0009-3775-5646</Identifier><AffiliationInfo><Affiliation>Department of Histology and Neuroanatomy, Faculty of Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Goki</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>United Graduate School of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokiya</LastName><ForeName>Mikiko</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1504-7795</Identifier><AffiliationInfo><Affiliation>Department of Social and Environmental Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitagawa</LastName><ForeName>Kyoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Ultrastructural Cell Biology, Department of Anatomy, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyake</LastName><ForeName>Yasunobu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3715-4022</Identifier><AffiliationInfo><Affiliation>Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kido</LastName><ForeName>Mizuho Aoki</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Histology and Neuroanatomy, Faculty of Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirota</LastName><ForeName>Yoshio</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5406-3240</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Research Center, SOUSEIKAI Medical Group (Medical Co., LTA), Fukuoka 813-0017, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8445-4071</Identifier><AffiliationInfo><Affiliation>Department of Social and Environmental Medicine, Saga University, Nabeshima, Saga 840-8501, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALDH2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">T cell</Keyword><Keyword MajorTopicYN="N">cellular immunity</Keyword><Keyword MajorTopicYN="N">enzyme-linked immunospot</Keyword><Keyword MajorTopicYN="N">rs671</Keyword></KeywordList><CoiStatement>Author Yoshio Hirota was employed by the company SOUSEIKAI Medical Group (Medical Co., LTA). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340045</ArticleId><ArticleId IdType="pmc">PMC11435883</ArticleId><ArticleId IdType="doi">10.3390/vaccines12091015</ArticleId><ArticleId IdType="pii">vaccines12091015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N., Britton G.J., Gruber C., Hegde S., Kim J., Kuksin M., Levantovsky R., Malle L., Moreira A., Park M.D., et al. Immunology of COVID-19: Current State of the Science. Immunity. 2020;52:910–941. doi: 10.1016/j.immuni.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Pérez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Farres J., Wang X., Takahashi K., Cunningham S.J., Wang T.T., Weiner H. Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase. A model to study human (Oriental type) class 2 aldehyde dehydrogenase. J. Biol. Chem. 1994;269:13854–13860. doi: 10.1016/S0021-9258(17)36725-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)36725-X</ArticleId><ArticleId IdType="pubmed">7910607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.F., Han C.L., Yin S.J. Substrate specificity of human and yeast aldehyde dehydrogenases. Chem. Biol. Interact. 2009;178:36–39. doi: 10.1016/j.cbi.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2008.10.002</ArticleId><ArticleId IdType="pubmed">18983993</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng G.S., Chen Y.C., Tsao T.P., Wang M.F., Yin S.J. Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet. Genom. 2007;17:845–855. doi: 10.1097/FPC.0b013e3282609e67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FPC.0b013e3282609e67</ArticleId><ArticleId IdType="pubmed">17885622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.H., Ferreira J.C., Gross E.R., Mochly-Rosen D. Targeting aldehyde dehydrogenase 2: New therapeutic opportunities. Physiol. Rev. 2014;94:1–34. doi: 10.1152/physrev.00017.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00017.2013</ArticleId><ArticleId IdType="pmc">PMC3929114</ArticleId><ArticleId IdType="pubmed">24382882</ArticleId></ArticleIdList></Reference><Reference><Citation>Moh I., Simon D., Gross E.R. The Alcohol Flush Response. Graph. Med. Rev. 2024;4:e807. doi: 10.7191/gmr.807.</Citation><ArticleIdList><ArticleId IdType="doi">10.7191/gmr.807</ArticleId><ArticleId IdType="pmc">PMC11185044</ArticleId><ArticleId IdType="pubmed">38895023</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks P.J., Enoch M.A., Goldman D., Li T.K., Yokoyama A. The alcohol flushing response: An unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;6:e50. doi: 10.1371/journal.pmed.1000050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000050</ArticleId><ArticleId IdType="pmc">PMC2659709</ArticleId><ArticleId IdType="pubmed">19320537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hishimoto A., Fukutake M., Mouri K., Nagasaki Y., Asano M., Ueno Y., Nishiguchi N., Shirakawa O. Alcohol and aldehyde dehydrogenase polymorphisms and risk for suicide: A preliminary observation in the Japanese male population. Genes. Brain Behav. 2010;9:498–502. doi: 10.1111/j.1601-183X.2010.00577.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1601-183X.2010.00577.x</ArticleId><ArticleId IdType="pubmed">20180859</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A. The bidirectional effect of defective ALDH2 polymorphism and disease prevention. Adv. Exp. Med. Biol. 2019;1193:69–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">31368098</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A., Nakashima C., Kimura S., Sueoka E., Aragane N. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies. BMC Cancer. 2021;21:584. doi: 10.1186/s12885-021-08329-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-021-08329-y</ArticleId><ArticleId IdType="pmc">PMC8140463</ArticleId><ArticleId IdType="pubmed">34022841</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A., Thompson D.C., Chen Y., Kitagawa K., Vasiliou V. Roles of defective ALDH2 polymorphism on liver protection and cancer development. Environ. Health Prev. Med. 2016;21:395–402. doi: 10.1007/s12199-016-0579-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12199-016-0579-2</ArticleId><ArticleId IdType="pmc">PMC5112207</ArticleId><ArticleId IdType="pubmed">27714678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y., Harada E., Morita S., Kinoshita K., Hayashida M., Shono M., Morikawa Y., Murohara T., Nakayama M., Yoshimura M., et al. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: Possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation. 2015;131:1665–1673. doi: 10.1161/CIRCULATIONAHA.114.013120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.013120</ArticleId><ArticleId IdType="pubmed">25759460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R.L., Tan C.H., Lu Y.C., Wu R.M. Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson’s disease. Sci. Rep. 2016;6:30424. doi: 10.1038/srep30424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30424</ArticleId><ArticleId IdType="pmc">PMC4958972</ArticleId><ArticleId IdType="pubmed">27453488</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A., Terashima Y., Toda E., Akao C., Miyake Y., Matsuo K., Shimanoe C., Nishida Y., Hara M., Tanaka K., et al. Reduced T cell immunity in variant ALDH2 allele carriers; Proceedings of the 91th Annual Meeting of the Japanese Society for Hygiene; Toyama, Japan. 6–8 March 2021.</Citation></Reference><Reference><Citation>Matsumoto A., Hara M., Ashenagar M.S., Tokiya M., Sawada T., Iwasaka C., Furukawa T., Kitagawa K., Miyake Y., Hirota Y. Variant Allele of ALDH2, rs671, Associates with Attenuated Post-Vaccination Response in Anti-SARS-CoV-2 Spike Protein IgG: A Prospective Study in the Japanese General Population. Vaccines. 2022;10:1035. doi: 10.3390/vaccines10071035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071035</ArticleId><ArticleId IdType="pmc">PMC9320019</ArticleId><ArticleId IdType="pubmed">35891198</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima S., Tokiya M., Izui K., Miyamoto H., Matsumoto A. Asian flush is a potential protective factor against COVID-19: A web-based retrospective survey in Japan. Environ. Health Prev. Med. 2024;29:14. doi: 10.1265/ehpm.23-00361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1265/ehpm.23-00361</ArticleId><ArticleId IdType="pmc">PMC10937249</ArticleId><ArticleId IdType="pubmed">38462476</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydyznski Moderbacher C., Ramirez S.I., Dan J.M., Grifoni A., Hastie K.M., Weiskopf D., Belanger S., Abbott R.K., Kim C., Choi J., et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell. 2020;183:996–1012.e1019. doi: 10.1016/j.cell.2020.09.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Devassikutty F.M., Jain A., Edavazhippurath A., Joseph M.C., Peedikayil M.M.T., Scaria V., Sandhya P., Govindaraj G.M. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature. Pediatr. Allergy Immunol. Pulmonol. 2021;34:115–118. doi: 10.1089/ped.2021.0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ped.2021.0002</ArticleId><ArticleId IdType="pmc">PMC8664121</ArticleId><ArticleId IdType="pubmed">34495748</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos-Barragan G., Wit N., Meiser J., Dingler F.A., Pietzke M., Mulderrig L., Pontel L.B., Rosado I.V., Brewer T.F., Cordell R.L., et al. Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism. Nature. 2017;548:549–554. doi: 10.1038/nature23481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23481</ArticleId><ArticleId IdType="pmc">PMC5714256</ArticleId><ArticleId IdType="pubmed">28813411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner M.A., Jorns M.S. Monomeric sarcosine oxidase: 2. Kinetic studies with sarcosine, alternate substrates, and a substrate analogue. Biochemistry. 2000;39:8825–8829. doi: 10.1021/bi000350y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi000350y</ArticleId><ArticleId IdType="pubmed">10913293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai L., Tan T., Tang Y., Yang J., Cui D., Wang R., Wang A., Fei X., Di Y., Wang X., et al. Endogenous formaldehyde is a memory-related molecule in mice and humans. Commun. Biol. 2019;2:446. doi: 10.1038/s42003-019-0694-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0694-x</ArticleId><ArticleId IdType="pmc">PMC6884489</ArticleId><ArticleId IdType="pubmed">31815201</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoeb M., Ansari N.H., Srivastava S.K., Ramana K.V. 4-Hydroxynonenal in the pathogenesis and progression of human diseases. Curr. Med. Chem. 2014;21:230–237. doi: 10.2174/09298673113209990181.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/09298673113209990181</ArticleId><ArticleId IdType="pmc">PMC3964795</ArticleId><ArticleId IdType="pubmed">23848536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yukawa Y., Ohashi S., Amanuma Y., Nakai Y., Tsurumaki M., Kikuchi O., Miyamoto S., Oyama T., Kawamoto T., Chiba T., et al. Impairment of aldehyde dehydrogenase 2 increases accumulation of acetaldehyde-derived DNA damage in the esophagus after ethanol ingestion. Am. J. Cancer Res. 2014;4:279–284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065408</ArticleId><ArticleId IdType="pubmed">24959382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulderrig L., Garaycoechea J.I., Tuong Z.K., Millington C.L., Dingler F.A., Ferdinand J.R., Gaul L., Tadross J.A., Arends M.J., O’Rahilly S., et al. Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response. Nature. 2021;600:158–163. doi: 10.1038/s41586-021-04133-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04133-7</ArticleId><ArticleId IdType="pubmed">34819667</ArticleId></ArticleIdList></Reference><Reference><Citation>Traverso N., Menini S., Maineri E.P., Patriarca S., Odetti P., Cottalasso D., Marinari U.M., Pronzato M.A. Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. J. Gerontol. A Biol. Sci. Med. Sci. 2004;59:B890–B895. doi: 10.1093/gerona/59.9.B890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/59.9.B890</ArticleId><ArticleId IdType="pubmed">15472151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Zhang Y., Ren J. ALDH2 Polymorphism and Ethanol Consumption: A Genetic-Environmental Interaction in Carcinogenesis. Adv. Exp. Med. Biol. 2019;1193:229–236.</Citation><ArticleIdList><ArticleId IdType="pubmed">31368108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali V.R., Ning R., Chen J., Yang X.P., Xu J., Palaniyandi S.S. Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin. Exp. Biol. Med. 2014;239:610–618. doi: 10.1177/1535370213520109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370213520109</ArticleId><ArticleId IdType="pmc">PMC4145606</ArticleId><ArticleId IdType="pubmed">24651616</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Forman H.J. 4-hydroxynonenal-mediated signaling and aging. Free Radic. Biol. Med. 2017;111:219–225. doi: 10.1016/j.freeradbiomed.2016.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.11.032</ArticleId><ArticleId IdType="pmc">PMC5438786</ArticleId><ArticleId IdType="pubmed">27876535</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S., Niikura M., Mineo S., Kobayashi F. Roles of IFN-γ and γδ T Cells in Protective Immunity Against Blood-Stage Malaria. Front. Immunol. 2013;4:258. doi: 10.3389/fimmu.2013.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00258</ArticleId><ArticleId IdType="pmc">PMC3756480</ArticleId><ArticleId IdType="pubmed">24009610</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Liao S., Zeng F., Liao Q., Luo G., Zhou Y. Effects of altered glycolysis levels on CD8(+) T cell activation and function. Cell Death Dis. 2023;14:407. doi: 10.1038/s41419-023-05937-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-023-05937-3</ArticleId><ArticleId IdType="pmc">PMC10329707</ArticleId><ArticleId IdType="pubmed">37422501</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Wang J., Jian F., Xiao T., Song W., Yisimayi A., Huang W., Li Q., Wang P., An R., et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602:657–663. doi: 10.1038/s41586-021-04385-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04385-3</ArticleId><ArticleId IdType="pmc">PMC8866119</ArticleId><ArticleId IdType="pubmed">35016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D., Saunders N., Maes P., Guivel-Benhassine F., Planchais C., Buchrieser J., Bolland W.H., Porrot F., Staropoli I., Lemoine F., et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602:671–675. doi: 10.1038/s41586-021-04389-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04389-z</ArticleId><ArticleId IdType="pubmed">35016199</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwin K.H., Stanley S.A. The aldehyde hypothesis: Metabolic intermediates as antimicrobial effectors. Open Biol. 2022;12:220010. doi: 10.1098/rsob.220010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.220010</ArticleId><ArticleId IdType="pmc">PMC9006002</ArticleId><ArticleId IdType="pubmed">35414258</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry S.B., Espich S., Thuong N.T.T., Chang X., Dorajoo R., Khor C.C., Heng C.K., Yuan J.M., Fox D., Anaya-Sanchez A., et al. Disruption of aldehyde dehydrogenase 2 protects against bacterial infection. bioRxiv. 2023 doi: 10.1101/2023.08.24.554661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.24.554661</ArticleId></ArticleIdList></Reference><Reference><Citation>Oota H., Pakstis A.J., Bonne-Tamir B., Goldman D., Grigorenko E., Kajuna S.L., Karoma N.J., Kungulilo S., Lu R.B., Odunsi K., et al. The evolution and population genetics of the ALDH2 locus: Random genetic drift, selection, and low levels of recombination. Ann. Hum. Genet. 2004;68:93–109. doi: 10.1046/j.1529-8817.2003.00060.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1529-8817.2003.00060.x</ArticleId><ArticleId IdType="pubmed">15008789</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiana G., Sun R., Huang J., Napolioni V., Ciccocioppo R. Infection burden and ALDH2 rs671, East Asian genetic diversity: A reply. Alcohol. Clin. Exp. Res. 2024 doi: 10.1111/acer.15403. Early View .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.15403</ArticleId><ArticleId IdType="pubmed">38937869</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiana G., Sun R., Huang J., Napolioni V., Ciccocioppo R. Contribution of infectious diseases to the selection of ADH1B and ALDH2 gene variants in Asian populations. Alcohol Clin. Exp. Res. 2024;48:855–866. doi: 10.1111/acer.15288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acer.15288</ArticleId><ArticleId IdType="pmc">PMC11073917</ArticleId><ArticleId IdType="pubmed">38462538</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon K.H., Hood B.L., Kim B.J., Hardwick J.P., Conrads T.P., Veenstra T.D., Song B.J. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology. 2006;44:1218–1230. doi: 10.1002/hep.21372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21372</ArticleId><ArticleId IdType="pubmed">17058263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.L., Lee Y.P., Wu M.L., Chi Y.C., Liu C.M., Lai C.L., Yin S.J. Inhibition of human alcohol and aldehyde dehydrogenases by aspirin and salicylate: Assessment of the effects on first-pass metabolism of ethanol. Biochem. Pharmacol. 2015;95:71–79. doi: 10.1016/j.bcp.2015.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2015.03.003</ArticleId><ArticleId IdType="pubmed">25772736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.P., Liao J.T., Cheng Y.W., Wu T.L., Lee S.L., Liu J.K., Yin S.J. Inhibition of human alcohol and aldehyde dehydrogenases by acetaminophen: Assessment of the effects on first-pass metabolism of ethanol. Alcohol. 2013;47:559–565. doi: 10.1016/j.alcohol.2013.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcohol.2013.09.001</ArticleId><ArticleId IdType="pubmed">24169088</ArticleId></ArticleIdList></Reference><Reference><Citation>Landin J.S., Cohen S.D., Khairallah E.A. Identification of a 54-kDa mitochondrial acetaminophen-binding protein as aldehyde dehydrogenase. Toxicol. Appl. Pharmacol. 1996;141:299–307. doi: 10.1016/S0041-008X(96)80036-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-008X(96)80036-6</ArticleId><ArticleId IdType="pubmed">8917703</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M., Yang Z., Wu Q., Yang Y., Zhao D., Cheng Q., Li Y., Liu G., Zhao C., Pan J., et al. IL-4-secreting CD40L(+) MAIT cells support antibody production in the peripheral blood of Heonch-Schönlein purpura patients. Inflamm. Res. 2024;73:35–46. doi: 10.1007/s00011-023-01816-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-023-01816-x</ArticleId><ArticleId IdType="pubmed">38147125</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>